Indian biopharma company Biocon sold a 9.96% stake in its unit and contract research firm Syngene International through open market sale, it said in an exchange filing. With the sale, the total promoter stake...
Sun Pharma buys Disperzyme, Phlogam brands from Aksigen Hospital Care
Indian drug major Sun Pharmaceutical Industries said it has bought anti-inflammatory brands Disperzyme, Disperzyme-CD, and Phlogam from Mumbai-based Aksigen Hospital Care for an undisclosed amount. All three brands are...
Slovenian company Krka eyeing promoter stake in Unichem
Slovenian pharmaceutical company Krka, d. d., Novo mesto is in discussions to acquire the promoter’s stake in Mumbai-based Unichem Laboratories, said two people aware of the development. Promoter Prakash Amrut Mody...
Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 cr
Advent International is expected to sign a binding agreement to buy Suven Pharmaceuticals, a Hyderabad-based listed contract research and manufacturing services (CRAMS) company, as early as Monday morning, people...
JB Pharma acquires cardiac brand from Glenmark for Rs 314 crore
JB Pharma on Wednesday said it has acquired cardiac brand Razel (rosuvastatin) for India and Nepal region from Glenmark for Rs 314 crore in an all-cash deal. The acquisition will be funded through long-term debt and...
Biocon completes $3.34 billion acquisition of Viatris’s biosimilar business
Biocon Biologics, a subsidiary of Biocon, announced the completion of the acquisition of the $3.34 billion Viatris’ global biosimilars business. Biocon Biologics will now recognize the combined revenue and associated...
Gland Pharma acquires French CDMO Cenexi for €120 million
Gland Pharma said that its Singapore subsidiary Gland Pharma International PTE has entered into an agreement to acquire 100% of France-based contract development & manufacturing organisation (CDMO) Cenexi Group for...
Mankind Pharma acquires majority stake in Upakarma Ayurveda
Mankind Pharma said it has acquired a majority stake in Upakarma Ayurveda, engaged in developing, manufacturing and selling ayurvedic and herbal products for an undisclosed amount. The company’s decision to invest...
Lupin’s Brazil subsidiary acquires 9 brands from Bausch Health
Drug maker Lupin said that its wholly-owned subsidiary in Brazil, MedQuímica Indústria Farmacêutica (MedQuímica), has signed a definitive agreement to acquire all rights to nine medicines from BL Indústria Ótica Ltda...
Medley-Cipla deal talks called off over valuation issues
Medley Pharmaceuticals has called off its sale after talks with lead contender Cipla failed on a valuation mismatch and differences over some agreement terms, multiple people aware of the development said. This is the...
InvAscent picks minority stake in domestic ophthalmic formulation firm Sunways for Rs 120 crore
Life Sciences and healthcare-focused private equity firm InvAscent has picked up a minority stake in Sunways India by investing Rs 120 crore ($15 million) from its India Life Sciences Fund III (ILSF III). Sunways...
CCI clears Abu Dhabi Investment Authority’s minority stake buy in Intas Pharmaceuticals
Anti-trust regulator Competition Commission of India (CCI) cleared Platinum Owl’s acquisition of a minority stake in Intas Pharmaceuticals. The proposed transaction involves a secondary acquisition by Platinum Owl...
